BURLINGTON, Mass., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, will present at the Biotech Showcase 2012 Conference on Wednesday, January 11, 2012 at 4:30 PM PT. A webcast of the presentation will be available at www.coronadobiosciences.com on the events page.
